| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely metformin hydrochloride 850 milligram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Saxagliptin hydrochloride (substance) |
Inferred relationship |
Some |
1 |
FHIR